BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 24284371)

  • 1. Evaluating the therapeutic effect of hepatocellular carcinoma treated with transcatheter arterial chemoembolization by magnetic resonance perfusion imaging.
    Chen X; Xiao E; Shu D; Yang C; Liang B; He Z; Bian D
    Eur J Gastroenterol Hepatol; 2014 Jan; 26(1):109-13. PubMed ID: 24284371
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Evaluation of the effect of transcatheter arterial chemoembolization in treatment of primary hepatocellular carcinoma with magnetic resonance diffusion-weighted imaging: 4-6-week follow-up of 25 cases].
    Fan WJ; Zhang L; Ouyang YS
    Zhonghua Yi Xue Za Zhi; 2008 Sep; 88(35):2474-7. PubMed ID: 19080627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcatheter intraarterial perfusion: MR monitoring of chemoembolization for hepatocellular carcinoma--feasibility of initial clinical translation.
    Larson AC; Wang D; Atassi B; Sato KT; Ryu RK; Lewandowski RJ; Nemcek AA; Mulcahy MF; Kulik LM; Miller FH; Salem R; Omary RA
    Radiology; 2008 Mar; 246(3):964-71. PubMed ID: 18309018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advanced hepatocellular carcinoma: treatment with high-intensity focused ultrasound ablation combined with transcatheter arterial embolization.
    Wu F; Wang ZB; Chen WZ; Zou JZ; Bai J; Zhu H; Li KQ; Jin CB; Xie FL; Su HB
    Radiology; 2005 May; 235(2):659-67. PubMed ID: 15858105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A comparative study of MRI manifestations and pathological changes in hepatocellular carcinoma treated by transcatheter arterial chemoembolization with lipiodol].
    Liu R; Wang JH; Zhou KR; Yan FH; Yan ZP; Shen JZ; Tan YS; Cai Y
    Zhonghua Gan Zang Bing Za Zhi; 2005 Oct; 13(10):754-8. PubMed ID: 16248948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The safety and efficacy of transcatheter arterial chemoembolization in the treatment of patients with hepatocellular carcinoma and main portal vein obstruction. A prospective controlled study.
    Lee HS; Kim JS; Choi IJ; Chung JW; Park JH; Kim CY
    Cancer; 1997 Jun; 79(11):2087-94. PubMed ID: 9179054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Image fusion with volume navigation of contrast enhanced ultrasound (CEUS) with computed tomography (CT) or magnetic resonance imaging (MRI) for post-interventional follow-up after transcatheter arterial chemoembolization (TACE) of hepatocellular carcinomas (HCC): Preliminary results.
    Ross CJ; Rennert J; Schacherer D; Girlich C; Hoffstetter P; Heiss P; Jung W; Feuerbach S; Zorger N; Jung EM
    Clin Hemorheol Microcirc; 2010; 46(2-3):101-15. PubMed ID: 21135486
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Application of DC beads in hepatocellular carcinoma: clinical and radiological results of a drug delivery device for transcatheter superselective arterial embolization.
    Sadick M; Haas S; Loehr M; Elshwi M; Singer MV; Brade J; Schoenberg SO; Diehl SJ
    Onkologie; 2010; 33(1-2):31-7. PubMed ID: 20164659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Computed tomography perfusion in evaluating the therapeutic effect of transarterial chemoembolization for hepatocellular carcinoma.
    Chen G; Ma DQ; He W; Zhang BF; Zhao LQ
    World J Gastroenterol; 2008 Oct; 14(37):5738-43. PubMed ID: 18837093
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Diagnostic value of computed tomographic perfusion imaging of whole liver for quantitative assessment of blood flow state in liver cancer after transcatheter arterial chemoembolization].
    Li SM; Gao ZL; Lyu XT; Jia J; Zhu P; Chen Y; Liu YL; Zhang ZX
    Zhonghua Gan Zang Bing Za Zhi; 2018 Jun; 26(6):429-435. PubMed ID: 30317756
    [No Abstract]   [Full Text] [Related]  

  • 11. Supplemental transcatheter arterial chemoembolization for hepatocellular carcinoma fed by collateral omental artery.
    Jia Z; Tian F; Li S; Wang K; Zhao J; Wang Y; Jiang L; Jiang G; Li M
    Hepatogastroenterology; 2014 Oct; 61(135):2042-6. PubMed ID: 25713908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of hepatocellular carcinoma vascularity before and after transcatheter arterial chemoembolization by using first pass perfusion weighted MR imaging.
    Zhao JG; Feng GS; Kong XQ; Li X; Li MH; Cheng YS
    World J Gastroenterol; 2004 Apr; 10(8):1152-6. PubMed ID: 15069716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early response of hepatocellular carcinoma to transcatheter arterial chemoembolization: choline levels and MR diffusion constants--initial experience.
    Chen CY; Li CW; Kuo YT; Jaw TS; Wu DK; Jao JC; Hsu JS; Liu GC
    Radiology; 2006 May; 239(2):448-56. PubMed ID: 16569781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparison of safety and efficacy for transcatheter arterial chemoembolization alone and plus radiofrequency ablation in the treatment of single branch portal vein tumor thrombus of hepatocellular carcinoma and their prognosis factors].
    Zhao M; Wang JP; Li W; Huang ZL; Zhang FJ; Fan WJ; Zhang L; Li XS; Pan CC; Wu PH
    Zhonghua Yi Xue Za Zhi; 2011 May; 91(17):1167-72. PubMed ID: 21756768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pseudolesion of the liver on gadoxetate disodium-enhanced MR images obtained after transarterial chemoembolization for hepatocellular carcinoma: clinicoradiologic correlation.
    Shinagawa Y; Sakamoto K; Fujimitsu R; Shimakura M; Kora S; Takano K; Yoshimitsu K
    AJR Am J Roentgenol; 2012 Nov; 199(5):1010-7. PubMed ID: 23096173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Study of local three-dimensional conformal radiotherapy combined with transcatheter arterial chemoembolization for patients with stage III hepatocellular carcinoma.
    Li B; Yu J; Wang L; Li C; Zhou T; Zhai L; Xing L
    Am J Clin Oncol; 2003 Aug; 26(4):e92-9. PubMed ID: 12902905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Long-term results of interventional treatment of large unresectable hepatocellular carcinoma (HCC): significant survival benefit from combined transcatheter arterial chemoembolization (TACE) and percutaneous ethanol injection (PEI) compared to TACE monotherapy].
    Lubienski A; Bitsch RG; Schemmer P; Grenacher L; Düx M; Kauffmann GW
    Rofo; 2004 Dec; 176(12):1794-802. PubMed ID: 15573291
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcatheter arterial chemoembolization through collateral arteries for hepatocellular carcinoma after arterial occlusion.
    Shibata T; Kojima N; Tabuchi T; Itoh K; Konishi J
    Radiat Med; 1998; 16(4):251-6. PubMed ID: 9814419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcatheter arterial chemoembolization (TACE) in hepatocellular carcinoma (HCC): the role of angiogenesis and invasiveness.
    Sergio A; Cristofori C; Cardin R; Pivetta G; Ragazzi R; Baldan A; Girardi L; Cillo U; Burra P; Giacomin A; Farinati F
    Am J Gastroenterol; 2008 Apr; 103(4):914-21. PubMed ID: 18177453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcatheter arterial chemoembolization confers survival benefit in patients with a spontaneously ruptured hepatocellular carcinoma.
    Kim JY; Lee JS; Oh DH; Yim YH; Lee HK
    Eur J Gastroenterol Hepatol; 2012 Jun; 24(6):640-5. PubMed ID: 22395224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.